Literature DB >> 28615246

Src family kinases in chronic kidney disease.

Jun Wang1, Shougang Zhuang2,3.   

Abstract

Src family kinases (SFKs) belong to nonreceptor protein tyrosine kinases and have been implicated in the regulation of numerous cellular processes, including cell proliferation, differentiation, migration and invasion, and angiogenesis. The role and mechanisms of SFKs in tumorgenesis have been extensively investigated, and some SFK inhibitors are currently under clinical trials for tumor treatment. Recent studies have also demonstrated the importance of SFKs in regulating the development of various fibrosis-related chronic diseases (e.g., idiopathic pulmonary fibrosis, liver fibrosis, renal fibrosis, and systemic sclerosis). In this article, we summarize the roles of SFKs in various chronic kidney diseases, including glomerulonephritis, diabetic nephropathy, human immunodeficiency virus-associated nephropathy, autosomal dominant form of polycystic kidney disease, and obesity-associated kidney disease, and discuss the mechanisms involved.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  diabetic nephropathy; fibrosis; glomerulonephritis; human immunodeficiency virus-associated nephropathy; nonreceptor protein tyrosine kinases

Mesh:

Substances:

Year:  2017        PMID: 28615246      PMCID: PMC5625110          DOI: 10.1152/ajprenal.00141.2017

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  81 in total

1.  Solution structure of the SH3 domain of Src and identification of its ligand-binding site.

Authors:  H Yu; M K Rosen; T B Shin; C Seidel-Dugan; J S Brugge; S L Schreiber
Journal:  Science       Date:  1992-12-04       Impact factor: 47.728

2.  Genomic Analysis of Kidney Allograft Injury Identifies Hematopoietic Cell Kinase as a Key Driver of Renal Fibrosis.

Authors:  Chengguo Wei; Li Li; Madhav C Menon; Weijia Zhang; Jia Fu; Brian Kidd; Karen L Keung; Christopher Woytovich; Ilana Greene; Wenzhen Xiao; Fadi Salem; Zhengzi Yi; John Cijiang He; Joel T Dudley; Barbara Murphy
Journal:  J Am Soc Nephrol       Date:  2016-12-07       Impact factor: 10.121

3.  Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.

Authors:  Wouter N Leonhard; Annemieke van der Wal; Zlata Novalic; Steven J Kunnen; Ron T Gansevoort; Martijn H Breuning; Emile de Heer; Dorien J M Peters
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-23

4.  Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies.

Authors:  L Barisoni; M Mokrzycki; L Sablay; M Nagata; H Yamase; P Mundel
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

5.  Activation of RhoA/ROCK regulates NF-κB signaling pathway in experimental diabetic nephropathy.

Authors:  Xi Xie; Jing Peng; Xiuting Chang; Kaipeng Huang; Juan Huang; Shaogui Wang; Xiaoyan Shen; Peiqing Liu; Heqing Huang
Journal:  Mol Cell Endocrinol       Date:  2013-01-30       Impact factor: 4.102

6.  Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study.

Authors:  V D'Agati; J I Suh; L Carbone; J T Cheng; G Appel
Journal:  Kidney Int       Date:  1989-06       Impact factor: 10.612

7.  IGF-I induces vascular endothelial growth factor in human mesangial cells via a Src-dependent mechanism.

Authors:  Gabriella Gruden; Shawanna Araf; Silvia Zonca; Davina Burt; Stephen Thomas; Luigi Gnudi; Giancarlo Viberti
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

8.  Heterogeneous nuclear ribonucleoprotein F suppresses angiotensinogen gene expression and attenuates hypertension and kidney injury in diabetic mice.

Authors:  Chao-Sheng Lo; Shiao-Ying Chang; Isabelle Chenier; Janos G Filep; Julie R Ingelfinger; Shao Ling Zhang; John S D Chan
Journal:  Diabetes       Date:  2012-06-04       Impact factor: 9.461

9.  Activation of Src mediates PDGF-induced Smad1 phosphorylation and contributes to the progression of glomerulosclerosis in glomerulonephritis.

Authors:  Akira Mima; Hideharu Abe; Kojiro Nagai; Hidenori Arai; Takeshi Matsubara; Makoto Araki; Kazuo Torikoshi; Tatsuya Tominaga; Noriyuki Iehara; Atsushi Fukatsu; Toru Kita; Toshio Doi
Journal:  PLoS One       Date:  2011-03-22       Impact factor: 3.240

10.  EGFR mediates hyperlipidemia-induced renal injury via regulating inflammation and oxidative stress: the detrimental role and mechanism of EGFR activation.

Authors:  Qilu Fang; Chunpeng Zou; Peng Zhong; Feng Lin; Weixin Li; Lintao Wang; Yali Zhang; Chao Zheng; Yi Wang; Xiaokun Li; Guang Liang
Journal:  Oncotarget       Date:  2016-04-26
View more
  25 in total

1.  uPAR isoform 2 forms a dimer and induces severe kidney disease in mice.

Authors:  Changli Wei; Jing Li; Brian D Adair; Ke Zhu; Jian Cai; Michael Merchant; Beata Samelko; Zhongji Liao; Kwi Hye Koh; Nicholas J Tardi; Ranadheer R Dande; Shuangxin Liu; Jianchao Ma; Salvatore Dibartolo; Stefan Hägele; Vasil Peev; Salim S Hayek; David J Cimbaluk; Melissa Tracy; Jon Klein; Sanja Sever; Sanford J Shattil; M Amin Arnaout; Jochen Reiser
Journal:  J Clin Invest       Date:  2019-04-02       Impact factor: 14.808

2.  Protein arginine methyltransferase 1 mediates renal fibroblast activation and fibrogenesis through activation of Smad3 signaling.

Authors:  Yu Zhu; Chao Yu; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2019-12-09

Review 3.  The New Biology of Diabetic Kidney Disease-Mechanisms and Therapeutic Implications.

Authors:  Yuliya Lytvyn; Petter Bjornstad; Daniel H van Raalte; Hiddo L Heerspink; David Z I Cherney
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

Review 4.  Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease.

Authors:  Mitchell I Parker; Anna S Nikonova; Danlin Sun; Erica A Golemis
Journal:  Cell Signal       Date:  2019-12-09       Impact factor: 4.315

Review 5.  Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease.

Authors:  Jonathan D Ravid; Mohamed Hassan Kamel; Vipul C Chitalia
Journal:  Nat Rev Nephrol       Date:  2021-03-23       Impact factor: 28.314

6.  Regulation of Fibroblast Cell Polarity by Src Tyrosine Kinase.

Authors:  Kazuo Katoh
Journal:  Biomedicines       Date:  2021-02-01

7.  Hypoxia Activates Src and Promotes Endocytosis Which Decreases MMP-2 Activity and Aggravates Renal Interstitial Fibrosis.

Authors:  Zhengyuan Cheng; Lei Liu; Zhi Wang; Yingying Cai; Qing Xu; Pingsheng Chen
Journal:  Int J Mol Sci       Date:  2018-02-15       Impact factor: 5.923

8.  New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011-2021) focussing on structure-activity relationship (SAR) and docking insights.

Authors:  Ahmed Elkamhawy; Eslam M H Ali; Kyeong Lee
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

9.  CO-Releasing Molecule-2 Prevents Acute Kidney Injury through Suppression of ROS-Fyn-ER Stress Signaling in Mouse Model.

Authors:  Md Jamal Uddin; Jeewon Jeong; Eun Seon Pak; Hunjoo Ha
Journal:  Oxid Med Cell Longev       Date:  2021-07-06       Impact factor: 6.543

Review 10.  The Emerging Role of Innate Immunity in Chronic Kidney Diseases.

Authors:  Philip Chiu-Tsun Tang; Ying-Ying Zhang; Max Kam-Kwan Chan; Winson Wing-Yin Lam; Jeff Yat-Fai Chung; Wei Kang; Ka-Fai To; Hui-Yao Lan; Patrick Ming-Kuen Tang
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.